P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY

Autor: Marie-Helene Delfau-Larue, Lucie Gomes, Guillaume Cartron, Franck Morschhauser, Francois-Xavier Gros, Thomas Gastinne, Lucie Oberic, Emmanuel Bachy, Pierre Feugier, Rémy Duléry, Cedric Menard, Celine Pangault, Alexis Claudel, Cathy Quelen, Cedric Portugues, Pierre-Julien Viailly, Francois Lemonnier, Emmanuel Itti, Clément Bailly, Camille Laurent, Roch Houot

Publikováno v: HemaSphere, Vol 7, p e5262795 (2023)

Externí odkaz: https://doaj.org/article/1d6d9b468a9a4d2d93e4bfc90ecca648

Corrigendum: Follicular lymphoma regulatory T-cell origin and function

Autor: Stéphane Rodriguez, Mehdi Alizadeh, Claire Lamaison, Alexis Saintamand, Céline Monvoisin, Rachel Jean, Laurent Deleurme, Jose Ignacio Martin-Subero, Céline Pangault, Michel Cogné, Patricia Amé-Thomas, Karin Tarte

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

Externí odkaz: https://doaj.org/article/858fed6b609e452cb08824915c58ded1

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a french multicenter clinical trial

Autor: Emmanuel GYAN, Delphine Rossille, Vincent Delwail, Corinne Haioun, Thierry Fest, Remy GRESSIN, Karin Tarte, Philippe Moreau, Eric DECONINCK, Delphine Maucort-Boulch, Celine PANGAULT, Noel Milpied, Guillaume Cartron, Steven Le gouill, Diane Damotte, Pierre-Louis Soubeyran

Publikováno v: Leukemia
Leukemia, 2014, 28 (12), pp.2367-2375. ⟨10.1038/leu.2014.137⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2014, 28 (12), pp.2367-2375. ⟨10.1038/leu.2014.137⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2014, 28, pp.2367-2375. 〈10.1038/leu.2014.137〉
Leukemia, Springer Nature, 2014, 28 (12), pp.2367-2375. ⟨10.1038/leu.2014.137⟩

The dosage of soluble programmed cell death ligand 1 (sPD-L1) protein in the blood of adults with cancer has never been performed in a prospective patient cohort. We evaluated the clinical impact of sPD-L1 level measured at the time of diagnosis for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1adad6764ea8d27dd995b8faa074fe0
https://univ-rennes.hal.science/hal-00981338

Targeting netrin‐1/DCC interaction in diffuse large B‐cell and mantle cell lymphomas

Autor: Laura Broutier, Marion Creveaux, Jonathan Vial, Antonin Tortereau, Jean‐Guy Delcros, Guillaume Chazot, Mark J McCarron, Sophie Léon, Céline Pangault, Nicolas Gadot, Amélie Colombe, Marie‐Laure Boulland, Jonathan Blachier, Julien C Marie, Alexandra Traverse‐Glehen, Olivier Donzé, Catherine Chassagne‐Clément, Gilles Salles, Karin Tarte, Patrick Mehlen, Marie Castets

Publikováno v: EMBO Molecular Medicine, Vol 8, Iss 2, Pp 96-104 (2016)

Abstract DCC (Deleted in Colorectal Carcinoma) has been demonstrated to constrain tumor progression by inducing apoptosis unless engaged by its ligand netrin‐1. This has been shown in breast and colorectal cancers; however, this tumor suppressive f

Externí odkaz: https://doaj.org/article/54487a895d0c470a8bb860763e426ec9

Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells

Autor: Virginie Pascal, Brice Laffleur, Arnaud Debin, Armelle Cuvillier, Marjolein van Egmond, Daniel Drocourt, Laurent Imbertie, Céline Pangault, Karin Tarte, Gérard Tiraby, Michel Cogné

Publikováno v: Haematologica, Vol 97, Iss 11 (2012)

Background While most antibody-based therapies use IgG because of their well-known biological properties, some functional limitations of these antibodies call for the development of derivatives with other therapeutic functions. Although less abundant

Externí odkaz: https://doaj.org/article/229e9afd88c64c1d9f457da071b1f191